🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 12 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/11/2023 | 54,49 | 55,26 | 52,72 | 53,21 | -1,44% | 4,66% | 71.700 |
| 03/11/2023 | 52,81 | 55,36 | 52,81 | 53,99 | +4,21% | 4,83% | 101.900 |
| 02/11/2023 | 53,96 | 53,96 | 51,70 | 51,81 | -2,80% | 4,19% | 83.400 |
| 01/11/2023 | 52,55 | 53,54 | 51,44 | 53,30 | +1,93% | 4,00% | 116.400 |
| 31/10/2023 | 50,87 | 52,67 | 50,87 | 52,29 | +2,79% | 3,54% | 77.200 |
| 30/10/2023 | 50,04 | 50,97 | 49,79 | 50,87 | +2,62% | 2,36% | 66.500 |
| 27/10/2023 | 51,33 | 51,77 | 49,24 | 49,57 | -2,92% | 4,93% | 89.200 |
| 26/10/2023 | 50,44 | 51,55 | 50,19 | 51,06 | +1,53% | 2,70% | 81.900 |
| 25/10/2023 | 51,50 | 52,22 | 49,75 | 50,29 | -3,08% | 4,80% | 122.300 |
| 24/10/2023 | 51,50 | 52,35 | 51,50 | 51,89 | +1,03% | 1,65% | 78.800 |
| 23/10/2023 | 52,04 | 52,22 | 51,35 | 51,36 | -1,40% | 1,67% | 96.100 |
| 20/10/2023 | 53,06 | 53,40 | 51,93 | 52,09 | -1,31% | 2,77% | 116.500 |
| 19/10/2023 | 53,80 | 53,98 | 52,58 | 52,78 | -2,11% | 2,60% | 87.800 |
| 18/10/2023 | 55,87 | 55,87 | 53,67 | 53,92 | -3,99% | 3,94% | 62.000 |
| 17/10/2023 | 56,43 | 57,33 | 56,01 | 56,16 | -0,46% | 2,34% | 81.500 |
| 16/10/2023 | 55,10 | 56,97 | 54,71 | 56,42 | +2,60% | 4,10% | 108.100 |
| 13/10/2023 | 55,29 | 55,79 | 54,67 | 54,99 | -0,47% | 2,03% | 62.700 |
| 12/10/2023 | 58,84 | 58,84 | 54,54 | 55,25 | -6,15% | 7,31% | 83.500 |
| 11/10/2023 | 60,00 | 60,00 | 58,32 | 58,87 | -2,45% | 2,80% | 70.500 |
| 10/10/2023 | 58,88 | 60,93 | 58,88 | 60,35 | +2,57% | 3,48% | 59.200 |
| 09/10/2023 | 57,74 | 58,94 | 57,71 | 58,84 | +1,19% | 2,13% | 74.100 |
| 06/10/2023 | 58,01 | 58,55 | 57,77 | 58,15 | +0,05% | 1,34% | 76.400 |
| 05/10/2023 | 58,37 | 58,85 | 57,97 | 58,12 | -0,36% | 1,51% | 80.200 |
| 04/10/2023 | 58,52 | 58,77 | 57,78 | 58,33 | -0,71% | 1,69% | 93.100 |
| 03/10/2023 | 59,07 | 59,40 | 58,21 | 58,75 | -0,71% | 2,01% | 96.400 |
| 02/10/2023 | 60,03 | 60,03 | 58,24 | 59,17 | -1,25% | 2,98% | 118.400 |
| 29/09/2023 | 61,96 | 61,96 | 59,69 | 59,92 | -2,55% | 3,66% | 109.400 |
| 28/09/2023 | 61,45 | 62,73 | 61,31 | 61,49 | +0,03% | 2,31% | 132.500 |
| 27/09/2023 | 60,48 | 61,79 | 60,26 | 61,47 | +2,09% | 2,53% | 145.400 |
| 26/09/2023 | 60,60 | 61,44 | 60,02 | 60,21 | +2,29% | 2,34% | 152.500 |